Previous work documented the potential of LAV-BPIFB4 gene therapy for the treatment of cardiovascular diseases and cardiomyopathies [20, 23, 24], More recently, we have gained evidence for the similar therapeutic value of directly using the encoded protein. Here, BPIFB4 is linked to cardiomyopathy.